WeVote
Log In

Bill

Bill

HF 2085

A bill for an act relating to the production and administration of psilocybin and providing penalties.

2025-2026 Regular Session Introduced by John Wills

Iowa bill establishes regulated psilocybin production and administration framework, creating legal therapeutic access while creating potential federal-state legal conflicts.

Introduced, referred to Health and Human Services.
#drugs #mushrooms #post-traumaticstressdisorders
0
WeVote Research Nonpartisan
Bill Summary · HF 2085

Legislative bill overview

HF 2085 establishes a regulatory framework for the production and administration of psilocybin in Iowa, creating legal pathways for its manufacture and use under state supervision. The bill specifies administrative procedures and penalties for violations related to psilocybin handling and distribution.

Why is this important

Psilocybin has shown clinical promise in treating depression, PTSD, and end-of-life anxiety in research settings, and several states have begun exploring regulated access models. Iowa's bill could position the state as either a pioneer in therapeutic psilocybin access or a cautious regulator, depending on implementation details—with significant implications for patients seeking alternative treatments and for research opportunities.

Potential points of contention

  • Federal-state conflict: Psilocybin remains a Schedule I controlled substance federally, creating legal uncertainty and potential conflicts with federal law enforcement and grant eligibility
  • Access vs. safety: Balancing therapeutic availability against abuse prevention and ensuring adequate oversight without restricting legitimate medical research
  • Implementation costs: Questions about funding for regulatory infrastructure, licensing, testing facilities, and state administration of the program

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.